We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

121 hedge funds and large institutions have $72.6M invested in Ampio Pharmaceuticals Inc. in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

728% more call options, than puts

Call options by funds: $1.94M | Put options by funds: $234K

11% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 28

3% less capital invested

Capital invested by funds: $75.2M → $72.6M (-$2.58M)

5% less funds holding

Funds holding: 128121 (-7)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
121
Holders Change
-7
Holders Change %
-5.47%
% of All Funds
2.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
31
Reduced
28
Closed
13
Calls
$1.94M
Puts
$234K
Net Calls
+$1.7M
Net Calls Change
-$599K
Name Holding Trade Value Shares
Change
Change in
Stake
Wolverine Trading
126
Wolverine Trading
Illinois
-$32.9K -71 Closed
TFS
127
Thoroughbred Financial Services
Tennessee
-$22K -44 Closed
PCM
128
Pinz Capital Management
New York
-$20K -41 Closed
VF
129
Virtu Financial
New York
-$19K -37 Closed
X
130
Xponance
Pennsylvania
-$17K -35 Closed
HPWA
131
Hall Private Wealth Advisors
North Carolina
-$17K -34 Closed
IA
132
IFG Advisory
Georgia
-$16K -34 Closed
Fidelity Investments
133
Fidelity Investments
Massachusetts
-$1K -2 Closed

AMPE Hedge Fund Activity: Q3 2021 in Review

121 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2021, worth a combined $72.6M — down 3.4% from $75.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AMPE and 7 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 31 added.

The largest buyer was State Street, adding an estimated $978K. The largest seller was First Trust Advisors, exiting entirely with an estimated $763K sold.

  • 121 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2021, down from 128 in Q2 2021.
  • Funds reported $72.6M of Ampio Pharmaceuticals Inc. stock for Q3 2021, down 3.4% quarter-over-quarter.
  • 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2021 and 13 closed out, a net change of -6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2021 was State Street, an estimated $978K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2021 was First Trust Advisors, an estimated $763K sold.

Based on aggregated 13F filings for Q3 2021.